PLOS ONE has retracted a 2012 article by a group of breast cancer researchers after another scientist — a leading U.S. oncologist — objected that the data came from his lab.
The paper, “GREB1 Functions as a Growth Promoter and Is Modulated by IL6/STAT3 in Breast Cancer,” came from a team composed of researchers at the Morehouse School of Medicine, Xavier University of Louisiana and the University of Miami School of Medicine. It purported to find that: Continue reading PLOS ONE retracts breast cancer genetics paper after claim of misappropriated data

Lawsuits are usually dry and boring, so it’s always fun to read one with a little life.





A Boston doctor indicted on charges of Medicare fraud in 2007 has had a paper relating to the case retracted this month.